Notice: Prescription Drug List (PDL): Multiple additions [2018-11-01]
Documents to announce multiple updates to the Prescription Drug List.
View ArticleNotice - PDL Amendment - Human and Veterinary Antimicrobials [2018-11-30]
Documents to announce multiple updates to the Prescription Drug List.
View ArticleNotice: Prescription Drug List (PDL): Multiple additions
Documents to announce multiple updates to the Prescription Drug List.
View ArticleStop illegal marketing of drugs and devices
Find out about the impacts of illegal marketing, illegal marketing techniques, how to file a marketing complaint, and how we handle the complaints we receive.
View ArticleSearch for clinical information on drugs and medical devices
Find data about the tests and trials that were performed on drugs and medical devices to evaluate their safety and efficacy.
View ArticleWhat we heard: A summary of scanning and consultations on what’s next for...
This report outlines the methodologies used to look ahead at the emerging health technology environment, the potential areas of focus that resulted, and the key findings from consultations.
View ArticleNotice of Consultation on the Prescription Drug List: Tramadol
Documents to announce a consultation to remove tramadol from the Prescription Drug List.
View ArticlePerformance Standards for the Fees in Respect of Drugs and Medical Devices Order
The purpose of this document is to provide the performance standards to be used to determine whether a remission should be granted, under the Fees in Respect of Drugs and Medical Devices Order (Order),...
View ArticleFinal Report: Fees for Drugs and Medical Devices
This document presents a summary of stakeholder comments and concerns, Health Canada's responses and the Final Fees for Drugs and Medical Devices which come into force April 1, 2020.
View ArticleNotice of Consultation on the Prescription Drug List: Vitamin D
Documents to announce a consultation to amend the Vitamin D qualifier on the Prescription Drug List.
View ArticleDrug and Medical Device Highlights 2018: Helping you maintain and improve...
Learn about the new and innovative drugs and medical devices that Health Canada approved for sale in Canada, the information we published about potential safety issues, and our other accomplishments in...
View ArticleNotice: Prescription Drug List (PDL): Multiple Additions
Documents to announce multiple updates to the Prescription Drug List.
View ArticleNotice of Consultation on the Prescription Drug List (PDL): Epinephrine...
Documents to announce a consultation to add epinephrine with a qualifier on the Prescription Drug List.
View ArticleDrug and Medical Device Highlights 2019: Helping you maintain and improve...
Learn about the new and innovative drugs and medical devices that Health Canada approved for sale in Canada, the information we published about potential safety issues, and our other accomplishments in...
View ArticleNotice: Prescription Drug List (PDL): Multiple additions [2020-07-15]
Documents to announce multiple updates to the Prescription Drug List.
View ArticleNotice: Prescription Drug List (PDL): Remdesivir (COVID-19) [2020-07-28]
Documents to announce addition of remdesivir to the Prescription Drug List.
View ArticleNotice – Prescription Drug List: Vitamin D
Documents to announce notice of intent to amend the Prescription Drug List for Vitamin D.
View ArticleNotice: Prescription Drug List (PDL): Multiple additions [2020-09-08]
Documents to announce multiple updates to the Prescription Drug List.
View ArticleInterim order on preventing and alleviating drug shortages in relation to...
The COVID-19 pandemic has caused an unprecedented demand for some drugs, contributed to drug shortages in Canada and posed a significant risk to the health of Canadians. This interim order (IO)...
View ArticleNotice Prescription Drug List (PDL): Bamlanivimab (COVID-19)
The purpose of this Notice of Amendment is to notify about the addition of bamlanivimab to the Prescription Drug List (PDL) for human and veterinary use.
View Article
